All Insights
Showing 1 - 12 of 1835
Life Sciences and Healthcare
EU revised device rules rebalance compliance towards simplification and proportionality
Commission proposal would streamline MDR and IVDR duties with flexible evidence, timeless certificates and tailored risk rules
Knowledge Notes
What business law changes can the UK expect in 2026?
Osborne Clarke's Knowledge Team looks at what's in store for business
Advertising and marketing regulation
Marketinglaw: December 2025
Welcome to the latest edition of Marketinglaw
Financial Services
Six a day? FCA sets out reconciliation rules to address safeguarding risks for UK payment and e-money firms
Steps include both internal and external safeguarding tests and a second 'day after receipt' check
Real estate
How can England and Wales solve its fly-tipping crisis?
Why legal reform is needed for faster court possession orders against trespassers
Life Sciences and Healthcare
European Parliament and Council provisional deal on new genomic techniques brings relaxation of gene editing a step closer
Two-tier categorisation of NGT plants endorsed alongside a patent ban rowback but patent transparency measures agreed
Life Sciences and Healthcare
EU's new bioeconomy strategy intends to harness sustainable innovation in life sciences and healthcare
Strategy aims to take advantage of 'biotechnology revolution', boost innovation and deliver sustainable solutions – what does this mean for
IT and data
UK Cyber Security and Resilience Bill: pragmatic overhaul or regulatory overload?
The key changes and action points for businesses, and how the bill compares with the EU NIS2
The Digital Markets Competition and Consumers Act (DMCCA)
UK CMA finalises guidance on price transparency under DMCCA and begins enforcement action
From holidays to fashion, fourteen sectors under scrutiny as the regulator finalises guidance on total price requirements
Life Sciences and Healthcare
The US BIOSECURE Act: is your supply chain at risk?
The legislation could be enacted by the end of the year, with potentially wide-ranging consequences for biotech companies undertaking federal
GDPR for HR
GDPR for HR | December 2025
Data subject access requests: the impact of AI, the Data (Use and Access) Act, and ICO enforcement
Life Sciences and Healthcare
EU triggers mandatory Eudamed use for diagnostics and medtech from May 2026
First modules declared functional under phased approach, with vigilance and clinical studies still to follow
